Trupanion (NASDAQ:TRUP) Price Target Lowered to $31.00 at Stifel Nicolaus

Trupanion (NASDAQ:TRUP) had its price target reduced by Stifel Nicolaus from $35.00 to $31.00 in a research report released on Tuesday,Benzinga reports. They currently have a hold rating on the financial services provider’s stock.

A number of other brokerages have also weighed in on TRUP. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Weiss Ratings cut shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Cantor Fitzgerald decreased their price target on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 14th. Finally, Piper Sandler lowered their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $44.50.

Trupanion Price Performance

Shares of Trupanion stock opened at $25.61 on Tuesday. The business has a 50 day simple moving average of $28.58 and a two-hundred day simple moving average of $35.46. Trupanion has a 12 month low of $24.32 and a 12 month high of $57.88. The stock has a market capitalization of $1.11 billion, a P/E ratio of 56.91 and a beta of 1.62. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.69 and a quick ratio of 1.69.

Trupanion (NASDAQ:TRUP) last released its earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.01). The firm had revenue of $376.85 million during the quarter, compared to analysts’ expectations of $375.89 million. Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The business’s revenue was up 11.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.04 EPS. As a group, analysts predict that Trupanion will post 0.13 EPS for the current fiscal year.

Insider Activity

In other Trupanion news, CFO Fawwad Qureshi sold 2,837 shares of the firm’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $26.46, for a total transaction of $75,067.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO John R. Gallagher sold 5,283 shares of Trupanion stock in a transaction on Friday, February 27th. The shares were sold at an average price of $26.52, for a total value of $140,105.16. Following the completion of the sale, the chief operating officer owned 32,387 shares in the company, valued at $858,903.24. This represents a 14.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 21,072 shares of company stock valued at $569,363. 5.42% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Trupanion

A number of hedge funds have recently modified their holdings of TRUP. Campbell & CO Investment Adviser LLC purchased a new stake in Trupanion in the 3rd quarter valued at about $3,772,000. GSA Capital Partners LLP boosted its stake in Trupanion by 827.3% during the third quarter. GSA Capital Partners LLP now owns 44,584 shares of the financial services provider’s stock worth $1,930,000 after buying an additional 39,776 shares during the period. Tudor Investment Corp ET AL increased its position in shares of Trupanion by 183.7% during the third quarter. Tudor Investment Corp ET AL now owns 237,125 shares of the financial services provider’s stock valued at $10,263,000 after acquiring an additional 153,530 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Trupanion by 66.7% during the second quarter. JPMorgan Chase & Co. now owns 161,781 shares of the financial services provider’s stock valued at $8,955,000 after acquiring an additional 64,704 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of Trupanion in the 3rd quarter valued at approximately $1,897,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.